Global footprints: Nigerian doctors blazing the trail

From groundbreaking research to life-saving innovations, NAOMI CHIMA writes on Nigerian doctors who are earning global recognition and reshaping the future of medicine

Bennet Omalu

Dr Bennet Omalu, a Nigerian-American physician, forensic pathologist and neuropathologist, gained international recognition for his research into chronic traumatic encephalopathy, a degenerative brain disease associated with repeated head impacts.
Born on September 30, 1968, Omalu grew up in Anambra State. He earned his Bachelor of Medicine and Bachelor of Surgery degree from the University of Nigeria, Nsukka, in 1990 before moving to the United States in 1994 for further training.
He subsequently undertook training in epidemiology at the University of Washington, completed pathology residency training at Harlem Hospital Center in New York and specialised in forensic pathology and neuropathology at the University of Pittsburgh. He also earned a Master of Public Health from the University of Pittsburgh and a Master of Business Administration from Carnegie Mellon University.
Omalu’s defining breakthrough came in 2002 when he examined the brain of Mike Webster, a former Pittsburgh Steelers player and Pro Football Hall of Famer who had died at the age of 50.
Although Webster’s brain appeared relatively normal to the naked eye, Omalu’s microscopic examination revealed abnormal accumulations of tau protein associated with neurological damage. His findings suggested that Webster had suffered from CTE, a condition previously documented in boxers.
Working with colleagues, Omalu published the findings in the medical journal Neurosurgery in 2005 in a paper titled Chronic Traumatic Encephalopathy in a National Football League Player.
The research sparked controversy. In 2006, members of the National Football League’s mild traumatic brain injury committee called for the paper’s retraction, disputing its interpretation of the findings. Omalu and his colleagues stood by their work, and the paper was not retracted.
His research helped bring wider scientific and public attention to the potential long-term consequences of repeated head trauma in contact sports. Subsequent studies by Omalu and other researchers further developed understanding of the condition.
His story reached a wider audience through the 2015 film, Concussion, starring Will Smith as Omalu and dramatising his investigation and the resistance his findings encountered.
Omalu also served as chief medical examiner for San Joaquin County, California, from 2007 to 2017, and has been associated with the University of California, Davis, as a clinical professor.
In 2016, he received the American Medical Association’s Distinguished Service Award in recognition of his contributions.
Omalu’s legacy lies in helping bring an overlooked medical problem into public discussion and advancing research into the effects of repetitive head injuries.

Samuel Achilefu

Nigerian-American biomedical engineer and scientist, Prof Samuel Achilefu, has built an international reputation for developing technologies designed to help doctors detect and treat diseases, particularly cancer.
He is the inaugural chair of the Department of Biomedical Engineering at the University of Texas Southwestern Medical Center in Dallas, where he also holds the Lyda Hill Distinguished University Chair and serves as a professor of radiology.
Born in Northern Nigeria, Achilefu pursued advanced studies in Europe before moving to the United States. He earned a PhD in molecular physical and materials chemistry from the University of Nancy in France in 1991 and undertook postdoctoral research at the University of Oxford between 1991 and 1993.
In 2001, he joined the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St Louis, where he spent more than two decades developing research programmes in cancer imaging and therapy.
His work focuses on molecular imaging, nanotechnology, optical imaging devices and contrast agents that help clinicians identify diseases and monitor biological processes.
One of his most widely recognised innovations is a wearable cancer-imaging system commonly known as cancer vision goggles. Used with targeted fluorescent dyes, the technology enables surgeons to visualise certain cancerous tissues under near-infrared light during operations.
The system is designed to help surgeons identify tumour margins more accurately and detect tissue that might otherwise be difficult to distinguish from healthy structures. Researchers continue to investigate the technology’s potential applications in different types of cancer surgery.
Achilefu has also explored light-activated therapies and nanomedicine approaches intended to improve cancer treatment while limiting damage to healthy tissue.
His contributions include more than 300 peer-reviewed scientific publications and over 70 issued United States patents, according to published institutional profiles.
In 2021, he was elected to the United States National Academy of Medicine in recognition of his contributions to optical imaging. In 2025, he was elected to the National Academy of Engineering for his work in molecular cancer imaging and nanotherapeutics.
He joined the University of Texas Southwestern Medical Center in 2022 to establish and lead its Department of Biomedical Engineering.
Achilefu’s career illustrates how collaboration between engineering, imaging science and clinical medicine can produce technologies that improve how doctors identify and treat disease.

Babaseyi Oyesola

Dr Babaseyi Oyesola is a Nigerian physician whose work has focused on improving access to surgical care in underserved communities.
An anaesthesiologist and critical-care physician, Oyesola is associated with CompactOR, a portable operating-room system popularly called the “Hospital in a Box”. Developed with engineering collaborators, the system was designed to bring essential surgical equipment to locations where conventional medical infrastructure is limited.
Oyesola was born in Nigeria and grew up in Cleveland, Ohio, in the United States. He later returned to Nigeria, where he studied at the College of Medicine, University of Lagos, graduating in 1986, according to published biographical accounts.
His professional career took him to the United Kingdom and the US. He worked as a consultant in anaesthesia and critical care at Medway Maritime Hospital in England and served as a visiting assistant professor at the University of California, Los Angeles, in 1998.
He also became involved in medical education, particularly simulation-based training, which allows healthcare professionals to practise procedures and emergency responses in controlled environments.
These experiences exposed him to the challenges faced by hospitals with limited equipment, unreliable electricity and inadequate facilities, informing his interest in developing practical solutions for healthcare delivery.
CompactOR was designed as a transportable operating-room system containing essential surgical and anaesthetic equipment. Its solar-powered configuration was intended to support operations in locations where dependable electricity may be unavailable.
The concept attracted international attention when Oyesola spoke at TEDGlobal in 2007. In his presentation, A Hospital Tour in Nigeria, he highlighted shortcomings in medical facilities and argued that improving healthcare required more than technology alone. Investment in infrastructure, training and better working conditions for medical professionals was also necessary.
His work has also been associated with Practice Ventures, a medical technology enterprise involved in supplying equipment and supporting medical training for African hospitals.
Oyesola’s career has included involvement in specialist medical services in Nigeria. In January 2014, Delta State University Teaching Hospital in Oghara, Delta State, performed its first successful kidney transplant in collaboration with a medical team from the University of Texas Southwestern Medical Center. The procedure was a collaborative achievement involving several medical specialists and should not be attributed to Oyesola alone.
His work reflects the broader challenge of delivering safe surgical care in communities where facilities, equipment and specialist personnel are scarce.
Through medical practice, technology initiatives and public advocacy, Oyesola has helped draw attention to the need for healthcare solutions adapted to underserved settings.

Oluyinka Olutoye

• Nigeria needs diaspora expertise to fix healthcare gaps — US-based doctor, Badero
• Nigerian doctor wins key UN committee post
• Medical students now plan japa before graduation — NMA

Dr Oluyinka Olutoye, a Nigerian-American paediatric and fetal surgeon, has earned international recognition for his work in treating life-threatening conditions before birth.
He is the surgeon-in-chief at Nationwide Children’s Hospital in Columbus, Ohio, where he oversees surgical services and continues to advance research and treatment in paediatric and fetal surgery.
Born in Lagos on January 15, 1967, Olutoye attended Lagos University Staff School and King’s College, Lagos, before studying medicine at Obafemi Awolowo University, Ile-Ife. He graduated with an MBChB degree in 1988.
He subsequently moved to the United States, earning a PhD in anatomy from Virginia Commonwealth University in 1996. He completed a general surgery residency at the Medical College of Virginia Hospitals before undertaking specialist training in paediatric and fetal surgery at the Children’s Hospital of Philadelphia.
Olutoye developed his clinical career at Texas Children’s Hospital in Houston, where he served as co-director of the Fetal Center and later as president of the medical staff. He also held professorial appointments at Baylor College of Medicine.
His work focuses on complex congenital conditions, including congenital diaphragmatic hernia and spina bifida, some of which can be treated before birth.
One of his most widely reported achievements came in 2016, when he co-led a surgical team at Texas Children’s Hospital that operated on a 23-week-old fetus diagnosed with a large sacrococcygeal teratoma, a rare tumour near the tailbone that threatened the baby’s survival.
The team temporarily removed the fetus from the uterus, removed most of the tumour and returned the baby to the womb. The pregnancy continued, and the baby, Lynlee Hope Boemer, was delivered by Caesarean section at about 36 weeks.
The case attracted global attention and became widely known as the story of the “baby born twice”. It demonstrated the potential of carefully selected fetal surgical interventions, although such procedures remain complex and carry significant risks.
Olutoye was appointed surgeon-in-chief at Nationwide Children’s Hospital in 2019. His research has included fetal wound healing, the treatment of severe congenital malformations before birth and the early detection of necrotising enterocolitis in premature infants.
He is also a fellow of several professional bodies, including the American College of Surgeons and the American Academy of Pediatrics. In 2020, he received Nigeria’s National Order of Merit Award for his contributions to medicine.
From his medical education in Nigeria to leadership at major American children’s hospitals, Olutoye’s career highlights the role of specialist research and surgical innovation in improving outcomes for some of the most vulnerable patients.

Stephen Odaibo

Dr Stephen G. Odaibo, a Nigerian-born physician with expertise in mathematics, computer science and ophthalmology, is working to improve the detection of eye diseases through Artificial Intelligence.
Raised in Ilorin, Kwara State, Odaibo attended University Primary School and Federal Government College, Ilorin, before travelling to the United States in 1998 to pursue higher education at the University of Alabama at Birmingham.
He earned a Bachelor’s degree in Mathematics in 2001 and a Master’s degree in 2002 through the university’s Mathematics Fast Track programme.
He later proceeded to Duke University, where he earned a master’s degree in computer science in 2009 and a medical degree in 2010. His training continued with an internship at Duke University Hospital, an ophthalmology residency at Howard University Hospital and specialist fellowship training in medical retina at the University of Michigan.
His multidisciplinary background has shaped his approach to medicine, allowing him to combine clinical experience with mathematical reasoning and computing.
As a retina specialist, Odaibo diagnoses and manages conditions affecting the light-sensitive tissue at the back of the eye. These include diabetic retinopathy, age-related macular degeneration and retinal vascular disorders.
He is also the co-founder and chief executive of RETINA-AI Health, a healthcare technology company developing artificial intelligence systems to support the detection of retinal diseases.
One of the company’s principal areas of focus is diabetic retinopathy, a complication of diabetes that can damage the retina and lead to vision loss if not identified and managed appropriately.
The technology is designed to analyse retinal images and help identify signs of disease, potentially making screening more accessible in primary-care settings where specialist eye doctors may be difficult to reach.
However, such systems require rigorous clinical validation to establish their accuracy, reliability and suitability for different patient populations.
Odaibo has also pursued academic interests in mathematical physics. He authored Quantum Mechanics and the MRI Machine in 2012 and The Form of Finite Groups: A Course on Finite Group Theory in 2016.
In 2017, the University of Alabama at Birmingham’s College of Arts and Sciences recognised his achievements with its Distinguished Alumni Achievement Award.
His career demonstrates how expertise acquired in mathematics and computer science can be applied to practical medical challenges, particularly the early detection of diseases that threaten vision.

Olurotimi Badero

Prof Olurotimi Badero has built a medical career around the relationship between two vital organs: the heart and the kidneys.
A physician trained in internal medicine, nephrology, cardiovascular medicine and interventional procedures, Badero has combined these specialities to address complex conditions involving the cardiovascular and renal systems.
He studied medicine at Obafemi Awolowo University, Ile-Ife, graduating in 1997, according to published profiles. He subsequently moved to the United States for postgraduate training, completing an internal medicine residency at SUNY Downstate Medical Center in Brooklyn, New York, before undertaking a fellowship in nephrology and hypertension at Emory University School of Medicine in Atlanta, Georgia.
His experience treating kidney patients exposed him to the complications that cardiovascular disease can create for people with impaired kidney function. This prompted him to pursue further training in cardiovascular medicine at SUNY Downstate.
He later undertook training in interventional cardiology and peripheral vascular intervention through programmes associated with Yale University School of Medicine and Bridgeport Hospital. He also received further training in interventional nephrology, endovascular medicine and dialysis-access intervention.
His multidisciplinary expertise underpins his work in interventional cardio-nephrology, an approach that brings cardiovascular and kidney care together to address patients whose conditions may affect both systems.
Badero’s clinical practice includes cardiovascular medicine, kidney care and minimally invasive procedures involving blood vessels. Such interventions can help doctors diagnose or treat certain conditions without resorting to more extensive surgery.
In the United States, he leads Cardiac Renal and Vascular Associates in Jackson, Mississippi, where his work includes specialist patient care and medical education.
His professional activities also extend to Nigeria. At Iwosan Lagoon Hospitals in Lagos, he serves as clinical head and director of the Interventional Cardiology Programme and Cardiac Catheterisation Laboratory.
The role provides a platform for applying his international experience to specialist cardiovascular services in Nigeria, where access to advanced diagnostic and interventional procedures remains an important healthcare concern.
In 2025, he was recognised by the University of Lagos as a Distinguished Fellow and Visiting Professor of Medicine, according to announcements by Iwosan Lagoon Hospitals.
His career has also attracted recognition in the United States, including a citation entered into the Congressional Record in 2016 acknowledging his medical training and professional contributions.
Badero is frequently described in professional profiles as the world’s first and only board-certified interventional cardio-nephrologist, although that distinction would require independent verification.
His career illustrates the value of combining specialist knowledge to address complex clinical problems and highlights the opportunities for experienced Nigerian medical professionals to contribute to healthcare delivery both abroad and at home.